Find Distigmine Bromide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 15876-67-2, Ubretid, Ubritil, Distigmini bromidum, Hexamarium, Bromure de distigmine
Molecular Formula
C22H32Br2N4O4
Molecular Weight
576.3  g/mol
InChI Key
GJHSNEVFXQVOHR-UHFFFAOYSA-L
FDA UNII
750F36OP6J

Distigmine Bromide
1 2D Structure

Distigmine Bromide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate;dibromide
2.1.2 InChI
InChI=1S/C22H32N4O4.2BrH/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20;;/h9-14,17-18H,5-8,15-16H2,1-4H3;2*1H/q+2;;/p-2
2.1.3 InChI Key
GJHSNEVFXQVOHR-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C[N+]1=CC=CC(=C1)OC(=O)N(C)CCCCCCN(C)C(=O)OC2=C[N+](=CC=C2)C.[Br-].[Br-]
2.2 Other Identifiers
2.2.1 UNII
750F36OP6J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Distigmine

2. Hexamarium

3. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, Dibromide

4. Ubretid

2.3.2 Depositor-Supplied Synonyms

1. 15876-67-2

2. Ubretid

3. Ubritil

4. Distigmini Bromidum

5. Hexamarium

6. Bromure De Distigmine

7. Bromuro De Distigmina

8. Distigminebromide

9. Hexamarium Bromide

10. Bc 51

11. Distigmine Dibromide

12. Bc-51

13. 750f36op6j

14. 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) Dibromide

15. (1-methylpyridin-1-ium-3-yl) N-methyl-n-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate;dibromide

16. 3,3'-(((hexane-1,6-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(1-methylpyridin-1-ium) Bromide

17. 3-hydroxy-1-methylpyridinium Bromide Hexamethylenebis-(n-methylcarbamate)

18. (1-methylpyridin-1-ium-3-yl) N-methyl-n-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate,dibromide

19. 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) Dibromide

20. Distigmini Bromidum [inn-latin]

21. Distigmine Bromide [inn:ban:jan]

22. Bromure De Distigmine [inn-french]

23. Einecs 240-013-0

24. Bromuro De Distigmina [inn-spanish]

25. Adcostigmine

26. Unii-750f36op6j

27. Ubretid (tn)

28. 3-hydroxy-1-methylpyridinium Bromide Hexamethylenebis(methylcarbamate)

29. Schembl148842

30. Distigmine Bromide [mi]

31. Chembl1098285

32. Distigmine Bromide [inn]

33. Distigmine Bromide [jan]

34. Chebi:31512

35. Distigmine Bromide (jp17/inn)

36. Dtxsid60935985

37. Distigmine Bromide [mart.]

38. Bcp16582

39. Distigmine Bromide [who-dd]

40. Mfcd00867188

41. Akos015914117

42. Pyridinium, 3-hydroxy-1-methyl-, Bromide, Hexamethylenebis(methylcarbamate)

43. Ac-8868

44. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, Dibromide

45. As-74357

46. Sy226319

47. Hy-119577

48. Cs-0070000

49. Ft-0718457

50. C72992

51. D01228

52. A855351

53. Q3277473

54. 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium)dibromide

55. 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) Dibromide

56. Hexamethylenebis(n-methylcarbaminoyl-1-methyl-3-hydroxypyridinium Bromide)

57. 1-methyl-3-{[methyl({6-[methyl({[(1-methylpyridin-1-ium-3-yl)oxy]carbonyl})amino]hexyl})carbamoyl]oxy}pyridin-1-ium Dibromide

58. 3,3-(((hexane-1,6-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(1-methylpyridin-1-ium) Bromide

59. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methyl-, Bromide (1:2)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 576.3 g/mol
Molecular Formula C22H32Br2N4O4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count11
Exact Mass576.07698 g/mol
Monoisotopic Mass574.07903 g/mol
Topological Polar Surface Area66.8 Ų
Heavy Atom Count32
Formal Charge0
Complexity487
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cholinesterase Inhibitors

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty